Special Issue "Acute and Chronic Urticaria: New Insights into Pathogenesis, Diagnosis and Therapy"
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 5405
Interests: food allergy; metal allergy; drug allergy; nasal cytology; immunotherapy; asthma; rhinitis; nasal polyposis.
Special Issues, Collections and Topics in MDPI journals
Urticaria is a predominantly mast cell–driven disease clinically characterized by wheals and/or angioedema. Urticaria is usually classified based on its duration as acute urticaria, lasting ≤ 6 weeks, or chronic urticaria, lasting > 6 weeks, including chronic spontaneous urticaria and chronic inducible urticaria. Its prevalence has been estimated at 1-2% affecting all age groups.
The etiopathogenesis of this disease is complex and unclear. Since chronic spontaneous urticaria is idiopathic, the search for causes, the optimization of treatment and the multidisciplinary approach to the disease are the pillars of research on this pathology. In addition, in recent years, significant advances in understanding the pathophysiological mechanisms of urticaria have prompted researchers to explore new drugs, particularly biologics, for patients with severe refractory urticaria.
In this Special Issue, we welcome papers (review and original article) that will cover all aspects of urticaria, which include:
- urticaria in special settings: childhood, pregnancies, immunodeficiencies;
- emerging pathophysiological aspects;
- diagnostic work-up;
- biomarkers of disease activity/severity and of the response to treatment;
- current and future therapeutic targets
Dr. Angela Rizzi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- acute urticaria
- chronic urticaria
- mast cells